The challenges of assessing adiposity in a clinical setting
This Perspective discusses the advantages and disadvantages of different methods of assessing adiposity in clinical settings.
This Perspective discusses the advantages and disadvantages of different methods of assessing adiposity in clinical settings.
Type 1 diabetes mellitus affects 8.5 million people globally and is characterized by autoimmune destruction of pancreatic β cells. This Review discusses cell replacement therapies for T1DM and outlines the challenges and future directions